Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV000788594 | SCV000927759 | likely pathogenic | not provided | 2018-06-21 | criteria provided, single submitter | clinical testing | |
Cavalleri Lab, |
RCV001095609 | SCV001251245 | likely pathogenic | Polycystic kidney disease, adult type | 2020-02-05 | criteria provided, single submitter | research | PM2, PM4, PP4, PP5 |
Centre for Mendelian Genomics, |
RCV001095609 | SCV001369026 | likely pathogenic | Polycystic kidney disease, adult type | 2019-04-09 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM4,PP3,PP4,PP5. |
ARUP Laboratories, |
RCV001095609 | SCV001473282 | uncertain significance | Polycystic kidney disease, adult type | 2019-12-20 | criteria provided, single submitter | clinical testing | The PKD1 c.8284_8295del; p.Ile2762_Arg2765del variant, also known as 8274_8285del, is reported in the literature in an individual with sporadic polycystic kidney disease (Neumann 2012). This variant is also reported in ClinVar (Variation ID: 636689). It is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. This variant deletes 4 amino acids leaving the rest of the protein in-frame. Although evidence suggests this variant may be pathogenic, the currently available information is insufficient to determine this with certainty. Therefore, the clinical significance of this variant is uncertain at this time. REFERENCES Neumann HP et al. Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes. Int Urol Nephrol. 2012 Dec;44(6):1753-62. |
RCV001095609 | SCV002558726 | likely pathogenic | Polycystic kidney disease, adult type | 2022-08-03 | criteria provided, single submitter | clinical testing |